Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas

Acta Neurochirurgica

Volumn 140, Issue 2, 1998, Pages 140-147

  Struikmans, H ^a   Rutgers, D H ^a   Jansen, G H ^a   Tulleken, C A F ^a   Van Der Tweel, I ^b   Battermann, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

DNA ploidy; Gliomas; Prognosis; Proliferation

Indexed keywords

BROXURIDINE; CELL MARKER; DNA;

ARTICLE; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMAN; HUMAN TISSUE; LABELING INDEX; MALE; MITOSIS; MULTIVARIATE ANALYSIS; NECROSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

BRAIN NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMANS; MALE; MIDDLE AGED; MITOSIS; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STATISTICS;

EID: 0031889673     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050075     Document Type: Article

References (52)

1. Barker II FG, Prados MD, Chang SM, Davis RL, Gutin PH, Lamborn KR, Larson DA, McDermott MW, Sneed PK, Wilson CB (1996) Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age and survival. Int J Rad Onc Biol Phys 34: 803-808
2. Beck HP (1980) Evaluation of flow cytometric data of human tumours. Correction procedures for background and cell aggregations. Cell Tiss Kinet 13: 173-181
3. Begg AC, McNally NJ, Shrieve DC (1985) A method to measure the duration of the DNA synthesis and the potential volume doubling time from a single sample. Cytometry 6: 620-626
4. Begg AC, Holland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Lefur R, van den Bogaert W, van Glahbeke M. Horiot JC (1990) The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumours: an interim report. Int J Radial Oncol Biol Phys 19: 1449-1453
5. Cho KG, Nagashima T, Barnwell S, Hoshino T (1988) Flow cytometric determination of model DNA population in relation to proliferative potential of human intracranial neoplasms. J Neurosurg 69: 588-592
6. Coons SW, Davis JR, Way DL (1988) Correlation of DNA content and histology in prognosis of astrocytomas. Am J Clin Path 90: 289-293
7. Coons SW, Johnson PJ, Pearl DK (1994) Prognostic significance of flow cytometry DNA analysis of human oligodendrogliomas Neurosurgery 34:680-687
8. Coons SW, Johnson PJ, Pearl DK (1994) Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytoms. Neurosurgery 35: 119-125
9. Curran WJ, Scott ChB jr, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85: 704-710
10. Danova M, Gactani P, Lombardi D, Giordano M, Riccardi A, Mazzini G(1991) Prognostic value of DNA ploidy and proliferutive activity in human malignant gliomas. Med Sci Res 19: 613-615
11. Danova M, Giaretti W, Merlo F, Mazzini, Gaetani P, Geido E, Gentile S, Bulti G, Di Vinci G, Riccardi A (1991) Prognostic significance of nuclear DNA content in human neuroepithelial tumours. Int J Cancer 48: 663-667
12. Darzynkicwicz Z, Traganos F, Kapuscinski J, Staino-Colco L, Melamed MR (1984) Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry 5: 355-363
13. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P (1988) Grading of astrocytoma a simple and reproducible method. Cancer 15: 2152-2165
14. Detta A, Hitchcock E (1990) Rapid estimation of the proliferaling index of brain tumours. J Neurooncol 8: 245-253
15. Deveaux BC, O'Fallon JR, Kelly PJ (1993) Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy and outcome. J Neurosurg 78:767-775
16. Dina AK, Kharbanda K, Sarkar C, Roy S, Mathur M, Banerji AK (1993) In-vivo proliferative potential of primary human brain tumours: its correlation with histological classification and morphological features in gliomas. Pathology 25: 4-9
17. Duncan GG, Goodman GB, Ludgate M, Rheaume DE (1992) The treatment of adult supratentorial high grade astrocytomas. J Neurooncol 13: 63-72
18. Ganju V, Jenkins RB, O'Fallon JR, Scheithauer BW, Ransom DT, Katzmann JA, Kimmel DW (1993) Prognostic factors in gliomas. A multivariate analysis of clinical, flow cytometric, cytogenetic, and molecular markers. Cancer 74: 920-927
19. Haapasalo HK, Sallinen PK, Helen PT, Rantala IS, Helm HJ, Isola JJ (1993) Comparison of three quanlitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms. J Pathol 171: 207-214
20. Hoshino T, Luis DM, Rodriquez A, Cho KG, Lee KS, Wilson CB (1988) Prognostic implications of the proliferative potential of low-grade astrocytomas. J Neurosurg 69: 839-842
21. Hoshino T, Ahn D, Prados MD, Mamborn K, Wilson CB (1993) Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 53: 550-555
22. Höyer M, Bentzen SM, Salling LN, Overgaard J (1994) Influence of sampling time on assessment of potential doubling time. Cytometry 16: 144-151
23. Ito S, Chandler KL, Prados MD, Lamborn K, Wynne J, Malec MK, Wilson CB, Davis RL, Hoshino T (1994) Proliferative potential and prognostic evaluation of low grade astrocytomas. J Neurooncol 19: 1-9
24. Kajiwara K, Orita T, Nishizaki T, Kamiryo T, Nakayama H, Ito H (1992) Glial fibrillary acidic protein (GFAP) expression and nucleolar organizer regions (NORs) in human gliomas. Brain Res 572: 314-318
25. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system tumours: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54
26. Kim DK, Hoyt J, Bacchi C, Keles GE, Mass M, Mayherg MR, Berger MS (1993) Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins. Neurosurgery 33:619-625
27. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3: 255-268
28. Kreth FW, Warnke PC, Scheremet R, Obertag CB (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762-766
29. Kross JM, Eden van CG, Vissers CJ, Mulder AK, Kwast van der TH (1992) Prognostic relevance of DNA flow cytometry in oligodendroglioma. Cancer 69: 1791-1798
30. Krouwer HGJ (1993) Histological and topographical variants of neuroepithelial tumours of the brain. Thesis, University Hospital Utrecht
31. Laperriere NJ, Bernstein M (1994) Radiotherapy for brain tumours. Canadian Cancer J Clin 44: 96-108
32. Linden van der PM (1981) An iterative method of analysis for DNA histograms. Acta Pathol Microbiol Scand [Suppl] 274: 133-137
33. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Boyko OB, Dodge RK, Kerns BJ, Burger PC (1994) Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 34: 674-679
34. Nelson DF, Diener West MD, Weinstein AS, Schoenfeld D, Nelson JS Sause WT, Chang CH, Goodman R, Carabell S (1986) A randomized comparison of misonidazol plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. Int J Radiat Onc Phys 12: 1793-1800
35. Nicoll JA, Candy E (1991) Nucleolar organizer regions and postoperative survival in glioblastoma multiforme. Neuropathol Appl Neurobiol 17: 17-20
36. Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H. Sasaki K (1989) Flow cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BrdUrd labeling indices in human brain tumours. J Neurosurg 70: 379-384
37. Nishizaki T, Orita T, Ikeda N, Oshita N, Nakayama H, Furtani Y, Ikeyama Y, Akimura T, Kamiryo T, Ito H (1990) Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence of brain tumour patients. J Neurosurg 73: 396-400
38. Ritter MA, Fowler JF, Kim Y, Lindstrom MJ, Kinsella TJ (1992) Single biopsy, tumour kinetic anlysis: a comparison of methods and an extension to shorter sampling intervals. Int J Radiat Oncol Biol Phys 23: 811-820
39. Ritter AM, Sawaya MD, Hess KR, Levin VA, Bruner JM (1994) Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme. Neurosurgery 35: 192-198
40. Salmon I, Kiss R, Dewitte O, Gras T, Pasteels JL, Brotchy J, Flament-Durand J (1992) Histopalhologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumour patients. Cancer 70: 538-546
41. Salmon I, Kiss R (1993) Relationship between proliferative activity and ploidy level in a series of 530 brain tumours, including astrocytomas, meningiomas, schwannomas, and metastasis. Human Pathol 24: 329-335
42. Schutte B, Reynderd MMJ, Van Assche CL, Hupperets PS, Bosnian FT, Blijham GH (1987) An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry 8: 372-376
43. Shapiro WR (1982) Treatment of neuroectodermal brain tumours. Ann Neurol 12: 231-237
44. Sheline GE (1990) Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys 18: 793-803
45. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Ashell SO, Nelson JS, Weinstein AS, Nelson DF (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Rad Oncol Biol Phys 26: 239-344
46. Steel GG (1977) Basic theory of growing cell populations. In: Steel GG (ed) Growth kinetics of tumours, Oxford University Press, London, pp 56-85
47. Vavruch L, Nordenskjöld B, Carstensen J, Eneström S (1996) Prognostic significance of flow cytometry and correlation to some conventional prognostic factors: a retrospective study of archival specimens of 134 astrocytomas. J Neurosurg 85: 146-151
48. Vecht CJ (1993) Effect of age on treatment decisions in lowgrade glioma. J Neurol Neurosurg Psychiatry 56: 1259-1264
49. Vertosick FT, Selker RG (1992) Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. Surg Neur 38: 359-363
50. White RA, Terry NHA (1992) A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine. Cytometry 13: 490-495
51. Wolley RC, Schrieber K, Koss LG, Kars M. Sherman S (1982) DNA distribution in human colon carcinomas and its relationships to clinical behaviour. J Natl Cancer Inst 69: 15-22
52. Zaprianow Z, Christow K (1988) Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumours. Cytometry 9: 380-386